Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 15/20 | 0.38 |
| ▸ | RXRB | P28702 | 13/20 | 0.38 |
| ▸ | RXRG | P48443 | 12/20 | 0.38 |
| ▸ | CYP26B1 | Q9NR63 | 2/20 | 0.33 |
| ▸ | CYP26A1 | O43174 | 2/20 | 0.32 |
| ▸ | RARB | P10826 | 3/20 | 0.32 |
| ▸ | RARA | P10276 | 2/20 | 0.32 |
| ▸ | RARG | P13631 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25127940 | 0.89 | RXRA (0.41) | RXRARXRBRXRGCYP26B1CYP26A1 | |
| SCHEMBL21846305 | 0.89 | RXRA (0.37) | RXRARXRBRXRGCYP26B1CYP26A1 | |
| SCHEMBL22600300 | 0.83 | RXRA (0.39) | RXRARXRBRXRGCYP26B1CYP26A1 | |
| SCHEMBL23117538 | 0.82 | RXRA (0.41) | RXRARXRBRXRGCYP26B1CYP26A1 | |
| SCHEMBL25126846 | 0.81 | PTAFR (0.31) | RXRARXRBRXRG | |
| SCHEMBL23567641 | 0.81 | RXRA (0.33) | RXRARXRBRXRGCYP26B1 | |
| SCHEMBL21190643 | 0.81 | TSHR (0.37) | — | |
| SCHEMBL22794879 | 0.80 | RXRA (0.30) | RXRARXRBRXRG | |
| SCHEMBL27339615 | 0.79 | RXRA (0.34) | RXRARXRBRXRG | |
| SCHEMBL23446085 | 0.79 | RXRA (0.36) | RXRARXRBRXRG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230096132-A1 | CYCLOALKANE-FUSED POLYCYCLIC AROMATIC COMPOUND | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2023-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230096132-A1 | CYCLOALKANE-FUSED POLYCYCLIC AROMATIC COMPOUND | LAGE3, ELOC, ELOB | RXRA 1898/4885RXRB 2857/4885RXRG 2600/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.